Annual Congress Berlin 2008

Saturday, 04.10.2008
Sunday, 05.10.2008
Monday, 06.10.2008
Tuesday, 07.10.2008
Wednesday, 08.10.2008

Citations should be made in the following way: Authors. Title. Eur Respir J 2008; 32: Suppl. 52, abstract number.

Material from 2008:

3952 Abstracts
658 Slide presentations
316 Webcasts
96 Handouts
1824 e-posters
316 Multimedia files

Material from 2008: Show

New treatments for asthma

Oral Presentation
Chairs: L. Allegra (Milano, Italy), I. M. Adcock (London, United Kingdom)

Download all media

Safety, efficacy and pharmacokinetics of inhaled TPI 1020 in smokers with asthma L. P. Boulet, C. Lemiere, G. Gauvreau, R. Olivenstein, D. Lougheed, B. Paradis, P. O‘Byrne, R. Pageau, P. Renzi (Ste-Foy/QC, Montreal/QC, Hamilton, ON, Montreal, QC, Kingston, ON, Laval, QC, Canada)
Hyaluronan prevents exercise induced bronchoconstriction in asthmatic children L. Allegra, S. Della Patrona, G. Petrigni (Milan, Italy)
Growth factor treatment for asthma by restoration of epithelial barrier function C. Xiao, V. Tear, S. Field, E. Vernon-Wilson, S. T. Holgate, S. M. Puddicombe, D. E. Davies, P. Monk (Southampton, United Kingdom)
A phase I single escalating intravenous (IV) dose of MEDI 563, an anti-IL5R_α antibody, in atopic asthma W. Busse, R. Katial, B. White, E. Gibiansky, A. Coyle, G. Spitalny, N. Molfino (Madison, WI, Denver, CO, Gaithersburg, MD, Princeton, NJ, United States Of America)
Single-dose, first-in-human study of AMG 317: safety and pharmacokinetics in healthy and asthmatic adults M. Vincent, C. Banfield, T. Kakkar, S. Shakib, R. Scicchitano, T. Cheah, J. Gerson (Thousand Oaks, CA, United States Of America; Adelaide, Australia)
A double-blind, placebo-controlled, study to assess the pharmacokinetics, safety and tolerability of multiple ascending intravenous doses of CAT 354, a recombinant human anti-IL13 antibody, in subjects with moderate asthma B. Bhowmick, D. Singh, N. Molfino, H. Cranmer, C. Birrell, R. Faggioni, L. Roskos, B. White, A. Woodcock (Manchester, Cambridge, United Kingdom)
Multiple-dose study of AMG 317 in adults with asthma: pharmacokinetics and safety C. Banfield, M. Vincent, T. Kakkar, M. Chia, F. Thien, T. Cheah, J. Gerson, C. Mayer, Y. Wu (Thousand Oaks, CA, United States Of America; Adelaide, Australia)
24-hour bronchodilator efficacy of single doses of indacaterol in patients with persistent asthma, and comparison with formoterol C. LaForce, P. Korenblat, P. Osborne, F. Dong, R. Owen, M. Higgins (North Carolina, Missouri, New Jersey, United States Of America; West Sussex, United Kingdom)